| carbidopa/levodopa / Generic mfg. |
| Ongoing | 4 | 200 | Europe | Sinemet, RVG 08740, Tablet, Sinemet | | There are no medical conditions or diseases under investigation., not applicable, Not possible to specify | | | | |
2008-006278-13: Motor function optimization in advanced Parkinson’s disease patients, combined with galantamine to prevent visual hallucinations. |
|
|
| Ongoing | 4 | 10 | Europe | Reminyl Retard, Sinemet 125 mg, Reminyl Retard, Sinemet 125 mg | UMCG | patients with advanced (>5 years) Parkinson\'s disease and visual hallucinations. | | | | |
2010-019897-33: Brain activation by addition of L-Dopa to normal antipsychotic treatment in patients with schizophrenia |
|
|
| Ongoing | 4 | 50 | Europe | Sinemet, Sinemet, Sinemet | erasmus mc, Erasmus MC | patients with psychotic symptoms, diagnosed with schizophrenia | | | | |
2013-004229-10: Placebo effect in Parkinson\'s disease El efecto placebo en la enfermedad de Parkinson |
|
|
| Ongoing | 4 | 60 | Europe | Sinemet 25/250, Sinemet 25/250 | Raul de la Fuente-Fernandez, Complejo Hospitalario Universitario de Ferrol (CHUF) | Parkinson\'s disease Enfermedad de Parkinson | | | | |
ChiCTR2000039201: Pharmacology of levodopa/carbidopa versus levodopa/benserazide in patients with parkinson's disease |
|
|
| Recruiting | 4 | 20 | | phase I: levodopa/carbidopa; phase II: levodopa/benserazide ;phase I: levodopa/benserazide; phase II: levodopa/carbidopa | The Affiliated Brain Hospital of Nanjing Medical University (Nanjing Brain Hospital); Brain Hospital of Nanjing Medical University, self-raised | Parkinson's disease | | | | |
2020-002754-24: Clinical study in early PD patients to investigate the effect of Opicapone 50mg or Levodopa 100 mg in the treatment of motor fluctuations. Estudio clínico en pacientes con EP temprana para investigar el efecto de Opicapone 50 mg o Levodopa 100 mg en el tratamiento de las fluctuaciones motoras. |
|
|
| Ongoing | 4 | 100 | Europe | Capsule, hard, Tablet, Ongentys 50 mg hard capsules, Madopar 125 mg T, tablets, SINEMET 100 mg + 25 mg tablets | Bial - Portela & Ca, S.A., Bial - Portela & Ca, S.A. | Parkinson's Disease (PD) Enfermedad de Parkinson (EP), Parkinson's Disease (PD) Enfermedad de Parkinson (EP), Diseases [C] - Nervous System Diseases [C10] | | | | |
NCT04742348: Research on Translational Outcomes of Alcohol (Project RETRO) |
|
|
| Withdrawn | 4 | 42 | NA | Carbidopa Levodopa, Placebo | University of Washington | Alcohol Drinking | 08/23 | 08/23 | | |
| Completed | 4 | 20 | US | Carbidopa Levodopa, Sinemet, L-DOPA, Placebo, Placebo tablet | Emory University, National Institute of Mental Health (NIMH) | Depression, Anhedonia | 10/23 | 10/23 | | |
| Recruiting | 4 | 70 | US | Carbidopa Levodopa, Sinemet, L-DOPA, Placebo, Placebo tablet | Emory University, National Institute of Mental Health (NIMH) | Anhedonia, Depression | 01/27 | 01/27 | | |
| Recruiting | 4 | 30 | US | Neurostimulation, Carbidopa 25/Levodopa 100Mg Tab | David Escobar, The Cleveland Clinic | Parkinson Disease | 06/28 | 06/28 | | |
